[en] Background: Secondary lymphedema is the main complication of oncological treatment in breast cancer affecting 1 in every 1,000 individuals who suffer from it. The fact of being a disease with such a high frequency of appearance, as well as of a chronic nature, makes it an important source of expenditure on healthcare resources ranging from, medical and physiotherapeutic visits more frequently, long periods of continuous medical therapy for life, orthopedic articles, etc. Currently, from the physiotherapeutic point of view, the treatment that is used is complex decongestive therapy (CDT); however, it offers a range of techniques that are so wide that it is not known which is the most effective in reducing lymphedema. In addition, methods with new resources that can bring significant improvements in this field. For this reason, it is important to be able to find out which is the therapy from which the lymphedema patient could benefit the most. Objetive: To find which technique is most effective in the treatment of secondary lymphedema to breast cancer: the TDC, multilayer bandage or neuromuscular bandage. Methods: A randomized clinical trial, experimental, analytical and prospective single-blind type is proposed. The sample will be formed by 78 female patients diagnosed of unilateral lymphedema in the upper extremity, between stage I and II and grade I to IIIa of at least 1 month of evolution, secondary to a breast cancer. The participants will be randomly distributed in three groups of 26 people each, so that the first group will receive CDT treatment, the second group will exclusively receive multilayer bandage and the third, as the second will receive neuromuscular bandage. The duration of the treatment will be once month for all the groups, preceded by a month of valuation. At the end of the interventions a re-evaluation will be carried out, repeating the process at 3 and 6 months after the same. The dependent variables raised in this study are: volume and circumference of the limb, pain, heaviness, involvement in the activities of daily life, quality of life, skin effects and functionality of the limb.

[gl] Introdución: O linfedema secundario é a principal complicación do tratamento oncolóxico no cancro de mama afectando a 1 de cada 1.000 individuos que o padece. O feito de ser unha enfermidade cunha frecuencia de aparición tan elevada, así como de carácter crónico, fai que sexa unha importante fonte de gastos en recursos sanitarios que abarcan dende, visitas médicas e fisioterapéuticas con maior frecuencia, largos períodos de terapia médica continua de por vida, artigos ortopédicos, etc. Actualmente, dende o punto de vista fisioterápico, o tratamento que se usa é a Terapia desconxestiva complexa (TDC); sen embargo, ofrece un abanico de técnicas tan amplas que se descoñece cal é aquela que ten maior eficacia na reducción do linfedema. Ademáis, comezan a aparecer métodos con novos recursos que poden aportar melloras significativas neste campo. Por iso, é importante poder atopar cal é aquela terapia da que máis se podría beneficiar o paciente con linfedema. Obxectivo: Determinar que técnica é máis eficaz no tratamento do linfedema secundario a cancro de mama: a TDC, a vendaxe multicapas ou a vendaxe neuromuscular. Material e método: Plantéxase a realización dun ensaio clínico aleatorio de tipo experimental, analítico e prospectivo a simple cego. A mostra estará formada por 78 pacientes mulleres diagnosticadas de linfedema unilateral na extremidade superior, entre o estadío I e II e o grado I ao IIIa de polo menos 1 mes de evolución, secundario a cancro de mama. As participantes serán distribuidas de maneira aleatoria en tres grupos de 26 persoas cada un, de maneira que, o primeiro recibirá como tratamento TDC, o segundo exclusivamente vendaxe multicapas e o terceiro de maneira idéntica ao anterior vendaxe neuromuscular. A duración do tratamento será de un mes para todos os grupos, precedido doutro mes de valoración exhaustiva de cada individuo. Ao finalizar as intervención efectuarase unha reevaluación, repetíndose o proceso aos 3 e 6 meses posteriores ao mesmo. As variables dependentes plantexadas neste estudo son: volumen e circunferencia do membro, dor, pesadez, afectación nas actividades da vida diaria, efectos na pel e funcionalidade do MS.